It reads as a very well balanced report to me.
3.9c target on Evolis and (relatively) near term diagnostic revenue expectations along. Significant further upside on each partnership deal that eventuates.
There would be some actual quarterly data partly underlying the hair product sales calculations and projections.
The report will now do the rounds and I expect it will be well received .... because, amongst other things it only prices the near term revenue streams.
cheers
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.977M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.7¢ | 0.6¢ | $1.885K | 272.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 680000 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1103713 | 3 |
View Market Depth
| Last trade - 15.53pm 11/07/2025 (20 minute delay) ? |
| AN1 (ASX) Chart |